Radiopharm Theranostics Ltd (RADX) Total Debt (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Total Debt of $183656.9 for Q2 2025, down 97.17% year-over-year from $6.5 million in Q2 2024, and down 97.17% quarter-over-quarter from $6.5 million in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Total Debt (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Total Debt for 2 consecutive years, with $183656.9 the latest figure, recorded in Q2 2025.
- In Q2 2025, Total Debt fell 97.17% year-over-year to $183656.9; the TTM figure through Jun 2025 stood at $183656.9 (down 97.17% YoY), while the FY2025 annual figure was $183656.9, up 2.81% from the prior year.
- Total Debt fell to $183656.9 in Q2 2025 per RADX's latest filing, from $6.5 million in the prior quarter.
- Across five years, Total Debt topped out at $6.5 million in Q2 2024 and bottomed at $183656.9 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 183,656.95 |
| Jun 30, 2024 | 6.50 Mn |